FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Molecular immunology2012; 51(2); 169-176; doi: 10.1016/j.molimm.2012.03.018

Expression of essential B cell development genes in horses with common variable immunodeficiency.

Abstract: Common variable immunodeficiency (CVID) is a heterogeneous disorder of B cell differentiation or function with inadequate antibody production. Our laboratory studies a natural form of CVID in horses characterized by late-onset B cell lymphopenia due to impaired B cell production in the bone marrow. This study was undertaken to assess the status of B cell differentiation in the bone marrow of CVID-affected horses by measuring the expression of genes essential for early B cell commitment and development. Standard RT-PCR revealed that most of the transcription factors and key signaling molecules that directly regulate B cell differentiation in the bone marrow and precede PAX5 are expressed in the affected horses. Yet, the expression of PAX5 and relevant target genes was variable. Quantitative RT-PCR analysis confirmed that the mRNA expression of E2A, PAX5, CD19, and IGHD was significantly reduced in equine CVID patients when compared to healthy horses (p<0.05). In addition, the PAX5/EBF1 and PAX5/B220 ratios were significantly reduced in CVID patients (p<0.01). Immunohistochemical analysis confirmed the absence of PAX5-BSAP expression in the bone marrow of affected horses. Our data suggest that B cell development seems to be impaired at the transition between pre-pro-B cells and pro-B cells in equine CVID patients.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Get Full Text
Publication Date: 2012-03-30 PubMed ID: 22464097PubMed Central: PMC3351080DOI: 10.1016/j.molimm.2012.03.018Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research dives into the investigation of gene expression associated with B cell development in horses affected by Common Variable Immunodeficiency (CVID), a disorder characterized by diminished antibody production. The findings showed that the expression of certain genes crucial for early B cell development was significantly reduced in affected horses, suggesting that B cell development might be impaired between two stages of differentiation: pre-pro-B cells and pro-B cells.

Understanding CVID in Horses

  • This study centered largely on horses suffering from a naturally occurring form of Common Variable Immunodeficiency (CVID). The affliction is a diverse disorder that hinders B cell differentiation – the process by which cells become specialized – or function, leading to inadequate production of antibodies.
  • In horses, this disease manifests as B cell lymphopenia that sets in late, predominantly due to impaired B cell production in the bone marrow.

Examining B cell Differentiation

  • The main aim of the study was to assess the status of B cell differentiation in the bone marrow of horses suffering from CVID. This was achieved by monitoring the expression of those genes that are crucial for early B cell development and commitment.
  • The researchers found most transcription factors and vital signaling molecules that directly control B cell differentiation within the bone marrow and that are expressed before the PAX5 gene were expressed in CVID-affected horses.
  • However, the expression of PAX5 and relevant target genes was inconsistent.

Reduced Gene Expression and Impaired B Cell Development

  • Quantitative RT-PCR analysis substantiated that mRNA expression for genes E2A, PAX5, CD19, and IGHD was markedly lower in horses with CVID compared to healthy horses. This difference was statistically significant (p<0.05).
  • The ratios of PAX5/EBF1 and PAX5/B220 – two critical parameters – were also found to be significantly lower in CVID patients (p<0.01).
  • Immunohistochemical analysis further verified the lack of PAX5-BSAP expression in the bone marrow of affected horses.
  • Based on these findings, it may be implied that the development of B cells is likely hindered at the transition stage between pre-pro-B cells and pro-B cells in equine CVID patients.

Cite This Article

APA
Tallmadge RL, Such KA, Miller KC, Matychak MB, Felippe MJ. (2012). Expression of essential B cell development genes in horses with common variable immunodeficiency. Mol Immunol, 51(2), 169-176. https://doi.org/10.1016/j.molimm.2012.03.018

Publication

Molecular immunology
ISSN: 1872-9142
NlmUniqueID: 7905289
Country: England
Language: English
Volume: 51
Issue: 2
Pages: 169-176

Researcher Affiliations

Tallmadge, R L
  • Equine Immunology Lab, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. rlt8@cornell.edu
Such, K A
    Miller, K C
      Matychak, M B
        Felippe, M J B

          MeSH Terms

          • Animals
          • B-Lymphocytes / cytology
          • B-Lymphocytes / immunology
          • Bone Marrow Cells / cytology
          • Bone Marrow Cells / immunology
          • Cell Differentiation / genetics
          • Cell Differentiation / immunology
          • Common Variable Immunodeficiency / genetics
          • Common Variable Immunodeficiency / immunology
          • Common Variable Immunodeficiency / veterinary
          • Horses
          • Immunohistochemistry
          • PAX5 Transcription Factor / genetics
          • Precursor Cells, B-Lymphoid / cytology
          • Precursor Cells, B-Lymphoid / immunology
          • Real-Time Polymerase Chain Reaction
          • Reverse Transcriptase Polymerase Chain Reaction

          Grant Funding

          • R03AI079796 / NIAID NIH HHS
          • DP2OD007216 / NIH HHS
          • DP2 OD007216 / NIH HHS
          • R03 AI079796-01 / NIAID NIH HHS
          • R03 AI079796 / NIAID NIH HHS
          • R03 AI079796-02 / NIAID NIH HHS
          • DP2 OD007216-01 / NIH HHS

          References

          This article includes 44 references
          1. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements.. Cell 1994 Dec 2;79(5):885-92.
            pubmed: 8001125doi: 10.1016/0092-8674(94)90077-9google scholar: lookup
          2. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.. Br J Haematol 2009 Jun;145(6):709-27.
            pmc: PMC2718064pubmed: 19344423doi: 10.1111/j.1365-2141.2009.07669.xgoogle scholar: lookup
          3. Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function.. Nat Immunol 2007 May;8(5):463-70.
            pubmed: 17440452doi: 10.1038/ni1454google scholar: lookup
          4. Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry.. Immunol Res 2007;38(1-3):78-86.
            pubmed: 17917013doi: 10.1007/s12026-007-0024-0google scholar: lookup
          5. Decker T, Pasca di Magliano M, McManus S, Sun Q, Bonifer C, Tagoh H, Busslinger M. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.. Immunity 2009 Apr 17;30(4):508-20.
            pubmed: 19345119doi: 10.1016/j.immuni.2009.01.012google scholar: lookup
          6. DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors.. Immunity 2002 Feb;16(2):297-309.
            pubmed: 11869689doi: 10.1016/s1074-7613(02)00269-8google scholar: lookup
          7. Drummond A, Ashton B, Cheung M, Heled J, Kearse M, Moir R, Stones-Havas S, Thierer T, Wilson A. Geneious v4.7. 2009.
          8. Ebert A, McManus S, Tagoh H, Medvedovic J, Salvagiotto G, Novatchkova M, Tamir I, Sommer A, Jaritz M, Busslinger M. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells.. Immunity 2011 Feb 25;34(2):175-87.
            pubmed: 21349430doi: 10.1016/j.immuni.2011.02.005google scholar: lookup
          9. Flaminio MJ, LaCombe V, Kohn CW, Antczak DF. Common variable immunodeficiency in a horse.. J Am Vet Med Assoc 2002 Nov 1;221(9):1296-302, 1267.
            pubmed: 12418696doi: 10.2460/javma.2002.221.1296google scholar: lookup
          10. Flaminio MJ, Tallmadge RL, Salles-Gomes CO, Matychak MB. Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.. J Clin Immunol 2009 Jan;29(1):107-16.
            pubmed: 18677444doi: 10.1007/s10875-008-9221-4google scholar: lookup
          11. Fuxa M, Skok JA. Transcriptional regulation in early B cell development.. Curr Opin Immunol 2007 Apr;19(2):129-36.
            pubmed: 17292598doi: 10.1016/j.coi.2007.02.002google scholar: lookup
          12. Hagman J, Lukin K. Transcription factors drive B cell development.. Curr Opin Immunol 2006 Apr;18(2):127-34.
            pubmed: 16464566doi: 10.1016/j.coi.2006.01.007google scholar: lookup
          13. Hao Z, Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow.. J Exp Med 2001 Oct 15;194(8):1151-64.
            pmc: PMC2193512pubmed: 11602643doi: 10.1084/jem.194.8.1151google scholar: lookup
          14. Horcher M, Souabni A, Busslinger M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.. Immunity 2001 Jun;14(6):779-90.
            pubmed: 11420047doi: 10.1016/s1074-7613(01)00153-4google scholar: lookup
          15. Kwon K, Hutter C, Sun Q, Bilic I, Cobaleda C, Malin S, Busslinger M. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development.. Immunity 2008 Jun;28(6):751-62.
            pubmed: 18538592doi: 10.1016/j.immuni.2008.04.014google scholar: lookup
          16. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG. Bcl11a is essential for normal lymphoid development.. Nat Immunol 2003 Jun;4(6):525-32.
            pubmed: 12717432doi: 10.1038/ni925google scholar: lookup
          17. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors.. Immunity 1995 Jul;3(1):147-61.
            pubmed: 7621074doi: 10.1016/1074-7613(95)90167-1google scholar: lookup
          18. Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL, Ikawa T, Murre C, Singh H, Hardy RR, Hagman J. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription.. Nat Immunol 2004 Oct;5(10):1069-77.
            pubmed: 15361869doi: 10.1038/ni1119google scholar: lookup
          19. Medina KL, Singh H. Gene regulatory networks orchestrating B cell fate specification, commitment, and differentiation.. Curr Top Microbiol Immunol 2005;290:1-14.
            pubmed: 16480036doi: 10.1007/3-540-26363-2_1google scholar: lookup
          20. Michaelson JS, Singh M, Birshtein BK. B cell lineage-specific activator protein (BSAP). A player at multiple stages of B cell development.. J Immunol 1996 Apr 1;156(7):2349-51.
            pubmed: 8786288
          21. Morrison AM, Nutt SL, Thévenin C, Rolink A, Busslinger M. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.. Semin Immunol 1998 Apr;10(2):133-42.
            pubmed: 9618759doi: 10.1006/smim.1998.0115google scholar: lookup
          22. Nutt SL, Morrison AM, Dörfler P, Rolink A, Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.. EMBO J 1998 Apr 15;17(8):2319-33.
            pmc: PMC1170575pubmed: 9545244doi: 10.1093/emboj/17.8.2319google scholar: lookup
          23. Nutt SL, Urbánek P, Rolink A, Busslinger M. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus.. Genes Dev 1997 Feb 15;11(4):476-91.
            pubmed: 9042861doi: 10.1101/gad.11.4.476google scholar: lookup
          24. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease.. Lancet 2008 Aug 9;372(9637):489-502.
            pubmed: 18692715doi: 10.1016/s0140-6736(08)61199-xgoogle scholar: lookup
          25. Pellegrini-Masini A, Bentz AI, Johns IC, Parsons CS, Beech J, Whitlock RH, Flaminio MJ. Common variable immunodeficiency in three horses with presumptive bacterial meningitis.. J Am Vet Med Assoc 2005 Jul 1;227(1):114-22, 87.
            pubmed: 16013546doi: 10.2460/javma.2005.227.114google scholar: lookup
          26. Ramírez J, Lukin K, Hagman J. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment.. Curr Opin Immunol 2010 Apr;22(2):177-84.
            pmc: PMC2854230pubmed: 20207529doi: 10.1016/j.coi.2010.02.003google scholar: lookup
          27. Roessler S, Györy I, Imhof S, Spivakov M, Williams RR, Busslinger M, Fisher AG, Grosschedl R. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.. Mol Cell Biol 2007 Jan;27(2):579-94.
            pmc: PMC1800812pubmed: 17101802doi: 10.1128/mcb.01192-06google scholar: lookup
          28. Salzer U, Neumann C, Thiel J, Woellner C, Pan-Hammarström Q, Lougaris V, Hagena T, Jung J, Birmelin J, Du L, Metin A, Webster DA, Plebani A, Moschese V, Hammarström L, Schäffer AA, Grimbacher B. Screening of functional and positional candidate genes in families with common variable immunodeficiency.. BMC Immunol 2008 Feb 7;9:3.
            pmc: PMC2268914pubmed: 18254984doi: 10.1186/1471-2172-9-3google scholar: lookup
          29. Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger GA, Busslinger M. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.. Immunity 2007 Jul;27(1):49-63.
            pubmed: 17658281doi: 10.1016/j.immuni.2007.05.019google scholar: lookup
          30. Sekine H, Ferreira RC, Pan-Hammarström Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, Novitzke J, Lee AT, Zhao N, Tompkins JD, Altshuler D, Gregersen PK, Cunningham-Rundles C, Harris RS, Her C, Nelson DL, Hammarström L, Gilkeson GS, Behrens TW. Role for Msh5 in the regulation of Ig class switch recombination.. Proc Natl Acad Sci U S A 2007 Apr 24;104(17):7193-8.
            pmc: PMC1855370pubmed: 17409188doi: 10.1073/pnas.0700815104google scholar: lookup
          31. Singh H, Medina KL, Pongubala JM. Contingent gene regulatory networks and B cell fate specification.. Proc Natl Acad Sci U S A 2005 Apr 5;102(14):4949-53.
            pmc: PMC555998pubmed: 15788530doi: 10.1073/pnas.0500480102google scholar: lookup
          32. Sitnicka E, Brakebusch C, Martensson IL, Svensson M, Agace WW, Sigvardsson M, Buza-Vidas N, Bryder D, Cilio CM, Ahlenius H, Maraskovsky E, Peschon JJ, Jacobsen SE. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis.. J Exp Med 2003 Nov 17;198(10):1495-506.
            pmc: PMC2194121pubmed: 14610045doi: 10.1084/jem.20031152google scholar: lookup
          33. Sitnicka E, Buza-Vidas N, Ahlenius H, Cilio CM, Gekas C, Nygren JM, Månsson R, Cheng M, Jensen CT, Svensson M, Leandersson K, Agace WW, Sigvardsson M, Jacobsen SE. Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors.. Blood 2007 Oct 15;110(8):2955-64.
            pubmed: 17540845doi: 10.1182/blood-2006-10-054726google scholar: lookup
          34. Tennent-Brown BS, Navas de Solis C, Foreman JH, Goetz TE, Fredrickson RL, Borst LB, Flaminio MJBF. Common variable immunodeficiency in a horse with chronic peritonitis. Equine vet Educ 2010;22(8):393–9.
          35. Thal MA, Carvalho TL, He T, Kim HG, Gao H, Hagman J, Klug CA. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage.. Proc Natl Acad Sci U S A 2009 Jan 13;106(2):552-7.
            pmc: PMC2626741pubmed: 19122139doi: 10.1073/pnas.0802550106google scholar: lookup
          36. Treiber T, Mandel EM, Pott S, Györy I, Firner S, Liu ET, Grosschedl R. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.. Immunity 2010 May 28;32(5):714-25.
            pubmed: 20451411doi: 10.1016/j.immuni.2010.04.013google scholar: lookup
          37. Urbánek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP.. Cell 1994 Dec 2;79(5):901-12.
            pubmed: 8001127doi: 10.1016/0092-8674(94)90079-5google scholar: lookup
          38. Wang H, Lee CH, Qi C, Tailor P, Feng J, Abbasi S, Atsumi T, Morse HC 3rd. IRF8 regulates B-cell lineage specification, commitment, and differentiation.. Blood 2008 Nov 15;112(10):4028-38.
            pmc: PMC2581985pubmed: 18799728doi: 10.1182/blood-2008-01-129049google scholar: lookup
          39. Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.. Proc Natl Acad Sci U S A 2009 Aug 18;106(33):13945-50.
            pmc: PMC2722504pubmed: 19666484doi: 10.1073/pnas.0903543106google scholar: lookup
          40. Wilmott RW. Delayed diagnosis in common variable immunodeficiency.. J Pediatr 2009 Jun;154(6):A1.
            pubmed: 19446082doi: 10.1016/j.jpeds.2009.04.019google scholar: lookup
          41. Yong PF, Thaventhiran JE, Grimbacher B. "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?. Adv Immunol 2011;111:47-107.
            pubmed: 21970952doi: 10.1016/b978-0-12-385991-4.00002-7google scholar: lookup
          42. Zandi S, Mansson R, Tsapogas P, Zetterblad J, Bryder D, Sigvardsson M. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.. J Immunol 2008 Sep 1;181(5):3364-72.
            pubmed: 18714008doi: 10.4049/jimmunol.181.5.3364google scholar: lookup
          43. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation.. Cell 1994 Dec 2;79(5):875-84.
            pubmed: 8001124doi: 10.1016/0092-8674(94)90076-0google scholar: lookup
          44. Zwollo P, Desiderio S. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.. J Biol Chem 1994 May 27;269(21):15310-7.
            pubmed: 8195169

          Citations

          This article has been cited 6 times.
          1. Pecoraro HL, Felippe MJB, Miller AD, Divers TJ, Simpson KW, Guyer KM, Duhamel GE. Neuroborreliosis in a horse with common variable immunodeficiency. J Vet Diagn Invest 2019 Mar;31(2):241-245.
            doi: 10.1177/1040638718824146pubmed: 30661472google scholar: lookup
          2. Ameratunga R, Koopmans W, Woon ST, Leung E, Lehnert K, Slade CA, Tempany JC, Enders A, Steele R, Browett P, Hodgkin PD, Bryant VL. Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clin Transl Immunology 2017 Oct;6(10):e159.
            doi: 10.1038/cti.2017.41pubmed: 29114388google scholar: lookup
          3. Prieto JMB, Tallmadge RL, Felippe MJB. Developmental expression of B cell molecules in equine lymphoid tissues. Vet Immunol Immunopathol 2017 Jan;183:60-71.
            doi: 10.1016/j.vetimm.2016.12.004pubmed: 28063478google scholar: lookup
          4. Badial PR, Tallmadge RL, Miller S, Stokol T, Richards K, Borges AS, Felippe MJ. Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses. Clin Vaccine Immunol 2015 Nov;22(11):1133-45.
            doi: 10.1128/CVI.00374-15pubmed: 26311245google scholar: lookup
          5. Tallmadge RL, Shen L, Tseng CT, Miller SC, Barry J, Felippe MJ. Bone marrow transcriptome and epigenome profiles of equine common variable immunodeficiency patients unveil block of B lymphocyte differentiation. Clin Immunol 2015 Oct;160(2):261-76.
            doi: 10.1016/j.clim.2015.05.005pubmed: 25988861google scholar: lookup
          6. Julia M, Felippe B. Equine common variable immunodeficiency: lessons from 100 clinical cases. Equine Vet Educ 2024 Oct;36(10):543-554.
            doi: 10.1111/eve.13948pubmed: 39555145google scholar: lookup
          Subscribe to our newsletter
          Join 99,658 horse owners like you who receive our email updates on horse health and nutrition.